Skip to main content
CRSP filings

Corporate insider profile

Simeon George Filing Activity

Latest reported as Director of CRISPR Therapeutics AG (CRSP).

Purchase filings
3
Reported companies
4
Net open-market value
$46,511,647
Latest transaction
Oct 14, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 14, 2026CRISPR Therapeutics AG (CRSP)DirectorSale14,514$49.63$720,373
Sep 28, 2026ADARx Pharmaceuticals, Inc. (ADRX)Director / 10% OwnerOpen Market Purchase1,600,000$17.00$27,200,000
May 11, 2026Odyssey Therapeutics, Inc. (ODTX)10% OwnerOpen Market Purchase557,335$18.00$10,032,030